News Headlines
-
Ropack Announces Significant Investments In Equipment And Automation Providing Immediate Capacity
6/27/2024
As Ropack approaches its 50th year in business, it is proud to announce significant expansion of its overall capabilities.
-
Novotech Announces MOU With Experienced Psychedelics Research Center At The 4th Annual Psychedelic Therapeutics And Drug Development Conference In Boston
6/24/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has signed an Memorandum of Understanding (MOU) with New Zealand Clinical Research (NZCR).
-
Construction And Validation Activities At The PCI Pharma Services Bedford, NH Campus Will Conclude Later This Year, With GMP Production Commencing In Early 2025
6/20/2024
Leading CDMO PCI Pharma Services has begun installation of key equipment for its newest sterile fill-finish facility on the company’s Bedford, NH campus.
-
Greenphire Launches Industry's First Patient Experience Dataset Transforming Clinical Trial Planning And Providing A View Into The Patient Journey
6/19/2024
Greenphire, a leading software innovator specializing in comprehensive solutions for streamlining clinical trials, today announced the launch of their new Patient Experience Dataset.
- OpenAI Selects Oracle Cloud Infrastructure To Extend Microsoft Azure AI Platform 6/14/2024
-
IQVIA Launches 'One Home' Clinical Trial Technology Platform – Solves Challenges And Reduces Overload At Sites
6/12/2024
One Home for Sites™ is a new technology platform that acts as a single sign-on and a single dashboard for the key systems and tasks a clinical research site needs to perform across all of the clinical trials it is conducting.
-
New Research Launched At BIO24 Finds CROs With In-House Regulatory Affairs Deliver 30% Savings, Halve Timelines And Cut Risk For Biotechs
6/4/2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.
-
Novotech Launches Dedicated Early Phase Unit For Biotechs Leveraging The Australian And New Zealand Clinical Environment
6/4/2024
Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced the launch of a dedicated early phase unit focussed on leveraging the unique advantage of Australian and New Zealand (ANZ) for early phase clinical development.
-
Novotech Signs Strategic MOU With Hong Kong-Shenzhen Innovation And Technology Park Limited (HSITPL)
5/31/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, today announced it has signed a Memorandum of Understanding (MOU) with Hong Kong-Shenzhen Innovation and Technology Park Limited (HSITPL).
-
Scout Announces Strategic Partnerships With 2 Top 20 Pharma Companies For Patient Services
5/30/2024
Scout is proud to announce the establishment of strategic partnerships with two leading pharmaceutical companies, both ranked within the top 20 globally.